Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 187

1.

Leukemic lineage switch in a t(8;22)(p11.2;q11.2)/BCR-FGFR1-rearranged myeloid/lymphoid neoplasm with RUNX1 mutation - diagnostic pitfalls and clinical management including FGFR1 inhibitor pemigatinib.

Manur R, Sung PJ, Loren AW, Ritchie EK, Frank D, Bagg A, Geyer JT, Bogusz AM.

Leuk Lymphoma. 2019 Sep 16:1-5. doi: 10.1080/10428194.2019.1660975. [Epub ahead of print] No abstract available.

PMID:
31524018
2.

Rosai-Dorfman Disease of the Breast With Variable IgG4+ Plasma Cells: A Diagnostic Mimicker of Other Malignant and Reactive Entities.

Hoffmann JC, Lin CY, Bhattacharyya S, Weinberg OK, Chisholm KM, Bayerl M, Cascio M, Venkataraman G, Allison K, Troxell M, Chang CC, Bagg A, George TI, O'Malley D, Ohgami RS.

Am J Surg Pathol. 2019 Aug 20. doi: 10.1097/PAS.0000000000001347. [Epub ahead of print]

PMID:
31436555
3.

Isolated Langerhans Cell Histiocytosis of the Lacrimal Gland in Conjunction With Mucosa-Associated Lymphoid Tissue Lymphoma and Elevated IgG4 Plasma Cells.

Peck T, Bagg A, Zhang X, Armstrong B, Eagle RC Jr, Milman T.

Ophthalmic Plast Reconstr Surg. 2019 Jul/Aug;35(4):e92-e94. doi: 10.1097/IOP.0000000000001399.

PMID:
31219941
4.

Longitudinal targeted next-generation sequencing in a patient with acute myeloid leukaemia.

Velu PD, Perl AE, Luger SM, Bagg A, Morrissette JJD.

Br J Haematol. 2019 Sep;186(6):801. doi: 10.1111/bjh.16048. Epub 2019 Jun 17. No abstract available.

PMID:
31206598
5.

Cyclin D1 expression and novel mutational findings in Rosai-Dorfman disease.

Baraban E, Sadigh S, Rosenbaum J, Van Arnam J, Bogusz AM, Mehr C, Bagg A.

Br J Haematol. 2019 Sep;186(6):837-844. doi: 10.1111/bjh.16006. Epub 2019 Jun 6.

PMID:
31172509
6.

Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms.

Patel SS, Ho C, Ptashkin RN, Sadigh S, Bagg A, Geyer JT, Xu ML, Prebet T, Mason EF, Seegmiller AC, Morgan EA, Steensma DP, Winer ES, Wong WJ, Hasserjian RP, Weinberg OK.

Blood Adv. 2019 May 14;3(9):1540-1545. doi: 10.1182/bloodadvances.2019000090.

7.

Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group.

Weinberg OK, Hasserjian RP, Baraban E, Ok CY, Geyer JT, Philip JKSS, Kurzer JH, Rogers HJ, Nardi V, Stone RM, Garcia JS, Hsi ED, Bagg A, Wang SA, Orazi A, Arber DA.

Mod Pathol. 2019 Sep;32(9):1373-1385. doi: 10.1038/s41379-019-0263-3. Epub 2019 Apr 18.

PMID:
31000771
8.

Hodgkin lymphoma patients have an increased incidence of idiopathic acquired aplastic anemia.

Linaburg T, Davis AR, Frey NV, Khawaja MR, Landsburg DJ, Schuster SJ, Svoboda J, Li Y, Borovskiy Y, Olson TS, Bagg A, Hexner EO, Babushok DV.

PLoS One. 2019 Apr 5;14(4):e0215021. doi: 10.1371/journal.pone.0215021. eCollection 2019.

9.

Myeloid neoplasm with eosinophilia and PCM1-JAK2 associated with acute promyelocytic leukemia with PML-RARA.

Salehi S, Astle JM, Sadigh S, Lake J, Aikawa V, Tang G, Wang SA, Bagg A.

Leuk Lymphoma. 2019 Sep;60(9):2299-2303. doi: 10.1080/10428194.2019.1581927. Epub 2019 Feb 26. No abstract available.

PMID:
30806106
10.

FBXW7 mutations in acute myeloid leukemia.

Sadigh S, Morrissette JJD, Bagg A.

Leuk Lymphoma. 2019 Jun;60(6):1601-1602. doi: 10.1080/10428194.2018.1537488. Epub 2019 Jan 11. No abstract available.

PMID:
30632836
11.

Genetic studies in the evaluation of myeloproliferative neoplasms.

Caponetti GC, Bagg A.

Semin Hematol. 2019 Jan;56(1):7-14. doi: 10.1053/j.seminhematol.2018.05.004. Epub 2018 May 28. Review.

PMID:
30573049
12.

Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study.

Tang G, Sydney Sir Philip JK, Weinberg O, Tam W, Sadigh S, Lake JI, Margolskee EM, Rogers HJ, Miranda RN, Bueso-Ramos C C, Hsi ED, Orazi A, Hasserjian RP, Arber DA, Bagg A, Wang SA.

Mod Pathol. 2019 Apr;32(4):490-498. doi: 10.1038/s41379-018-0165-9. Epub 2018 Nov 6.

PMID:
30401948
13.

High-throughput sequencing of the T-cell receptor β chain gene distinguishes 2 subgroups of cutaneous T-cell lymphoma.

Wang J, Rea B, Haun P, Emerson R, Kirsch I, Bagg A.

J Am Acad Dermatol. 2019 Apr;80(4):1148-1150.e1. doi: 10.1016/j.jaad.2018.10.027. Epub 2018 Oct 23. No abstract available.

PMID:
30365996
14.

Expedited Analysis and Reporting of Multiple Mutations that Modify Medical Management of Myeloid Malignancies: It's About (Turnaround) Time!

Kluk MJ, Bagg A.

J Mol Diagn. 2019 Jan;21(1):13-15. doi: 10.1016/j.jmoldx.2018.09.001. Epub 2018 Oct 19.

PMID:
30347269
15.

Genetic Inactivation of CD33 in Hematopoietic Stem Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia.

Kim MY, Yu KR, Kenderian SS, Ruella M, Chen S, Shin TH, Aljanahi AA, Schreeder D, Klichinsky M, Shestova O, Kozlowski MS, Cummins KD, Shan X, Shestov M, Bagg A, Morrissette JJD, Sekhri P, Lazzarotto CR, Calvo KR, Kuhns DB, Donahue RE, Behbehani GK, Tsai SQ, Dunbar CE, Gill S.

Cell. 2018 May 31;173(6):1439-1453.e19. doi: 10.1016/j.cell.2018.05.013. Epub 2018 May 31.

16.

JAK2 V617F-positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group.

Aynardi J, Manur R, Hess PR, Chekol S, Morrissette JJD, Babushok D, Hexner E, Rogers HJ, Hsi ED, Margolskee E, Orazi A, Hasserjian R, Bagg A.

Br J Haematol. 2018 Jul;182(1):78-85. doi: 10.1111/bjh.15276. Epub 2018 May 16.

PMID:
29767839
17.

Role of high-throughput sequencing in the diagnosis of cutaneous T-cell lymphoma.

Rea B, Haun P, Emerson R, Vignali M, Farooqi M, Samimi S, Elenitsas R, Kirsch I, Bagg A.

J Clin Pathol. 2018 Sep;71(9):814-820. doi: 10.1136/jclinpath-2018-205004. Epub 2018 Apr 10.

PMID:
29636372
18.

A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 Criteria.

Margolskee E, Mikita G, Rea B, Bagg A, Zuo Z, Sun Y, Goswami M, Wang SA, Oak J, Arber DA, Allen MB, George TI, Rogers HJ, Hsi E, Hasserjian RP, Orazi A.

Mod Pathol. 2018 Jun;31(6):873-880. doi: 10.1038/s41379-018-0001-2. Epub 2018 Feb 5.

19.

T-Cell Large Granular Lymphocytic Leukemia and Coexisting B-Cell Lymphomas: A Study From the Bone Marrow Pathology Group.

Goyal T, Thakral B, Wang SA, Bueso-Ramos CE, Shi M, Jevremovic D, Morice WG, Zhang QY, George TI, Foucar KK, Bhattacharyya S, Bagg A, Rogers HJ, Bodo J, Durkin L, Hsi ED.

Am J Clin Pathol. 2018 Jan 29;149(2):164-171. doi: 10.1093/ajcp/aqx146.

PMID:
29365010
20.

Next-Generation Sequencing for Lymphomas: Perfecting a Pipeline for Personalized Pathobiologic and Prognostic Predictions.

Ohgami RS, Rosenwald A, Bagg A.

J Mol Diagn. 2018 Mar;20(2):163-165. doi: 10.1016/j.jmoldx.2018.01.002. Epub 2018 Feb 2.

PMID:
29355824
21.

Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group.

Soderquist CR, Ewalt MD, Czuchlewski DR, Geyer JT, Rogers HJ, Hsi ED, Wang SA, Bueso-Ramos CE, Orazi A, Arber DA, Hexner EO, Babushok DV, Bagg A.

Mod Pathol. 2018 May;31(5):690-704. doi: 10.1038/modpathol.2017.182. Epub 2018 Jan 12.

22.

Molecular Malfeasance Mediating Myeloid Malignancies: The Genetics of Acute Myeloid Leukemia.

King RL, Bagg A.

Methods Mol Biol. 2017;1633:1-17. doi: 10.1007/978-1-4939-7142-8_1. Review.

PMID:
28735477
23.

NPM1 for MRD? Droplet Like It's Hot!

Wertheim GBW, Bagg A.

J Mol Diagn. 2017 Jul;19(4):498-501. doi: 10.1016/j.jmoldx.2017.04.008.

PMID:
28645444
24.

Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia.

Geyer JT, Tam W, Liu YC, Chen Z, Wang SA, Bueso-Ramos C, Oak J, Arber DA, Hsi E, Rogers HJ, Levinson K, Bagg A, Hassane DC, Hasserjian RP, Orazi A.

Mod Pathol. 2017 Sep;30(9):1213-1222. doi: 10.1038/modpathol.2017.45. Epub 2017 May 26.

25.

Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome.

Wang SA, Hasserjian RP, Tam W, Tsai AG, Geyer JT, George TI, Foucar K, Rogers HJ, Hsi ED, Rea BA, Bagg A, Bueso-Ramos CE, Arber DA, Verstovsek S, Orazi A.

Haematologica. 2017 Aug;102(8):1352-1360. doi: 10.3324/haematol.2017.165340. Epub 2017 May 11.

26.

Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter Study.

Rogers HJ, Hsi ED, Tang G, Wang SA, Bueso-Ramos CE, Lubin D, Morrissette JJ, Bagg A, Cherukuri DP, George TI, Peterson L, Liu YC, Mathew S, Orazi A, Hasserjian RP.

Am J Clin Pathol. 2017 Apr 1;147(4):411-419. doi: 10.1093/ajcp/aqx020.

PMID:
28375434
27.

International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.

Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, Simpson D, Liu AY, Menke D, Chandrakasan S, Lechowicz MJ, Wong RS, Pierson S, Paessler M, Rossi JF, Ide M, Ruth J, Croglio M, Suarez A, Krymskaya V, Chadburn A, Colleoni G, Nasta S, Jayanthan R, Nabel CS, Casper C, Dispenzieri A, Fosså A, Kelleher D, Kurzrock R, Voorhees P, Dogan A, Yoshizaki K, van Rhee F, Oksenhendler E, Jaffe ES, Elenitoba-Johnson KS, Lim MS.

Blood. 2017 Mar 23;129(12):1646-1657. doi: 10.1182/blood-2016-10-746933. Epub 2017 Jan 13.

28.

The cytological features of CAR(T) cells.

Brooks S, Frey N, Porter D, June C, Lacey S, Bagg A.

Br J Haematol. 2016 Nov;175(3):366. doi: 10.1111/bjh.14286. Epub 2016 Sep 9. No abstract available.

PMID:
27612286
29.

BRAF kinase domain mutations in de novo acute myeloid leukemia with monocytic differentiation.

Xu Y, Wertheim G, Morrissette JJ, Bagg A.

Leuk Lymphoma. 2017 Mar;58(3):743-745. doi: 10.1080/10428194.2016.1213830. Epub 2016 Aug 22. No abstract available.

PMID:
27545333
30.

Pediatric chronic myeloid leukemia with inv(3)(q21q26.2) and T lymphoblastic transformation: a case report.

Lewen M, Gresh R, Queenan M, Paessler M, Pillai V, Hexner E, Frank D, Bagg A, Aplenc R, Caywood E, Wertheim G.

Biomark Res. 2016 Jul 22;4:14. doi: 10.1186/s40364-016-0069-0. eCollection 2016.

31.

Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified.

Wang SA, Tam W, Tsai AG, Arber DA, Hasserjian RP, Geyer JT, George TI, Czuchlewski DR, Foucar K, Rogers HJ, Hsi ED, Bryan Rea B, Bagg A, Dal Cin P, Zhao C, Kelley TW, Verstovsek S, Bueso-Ramos C, Orazi A.

Mod Pathol. 2016 Aug;29(8):854-64. doi: 10.1038/modpathol.2016.75. Epub 2016 May 13.

32.

Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy.

Bhoj VG, Arhontoulis D, Wertheim G, Capobianchi J, Callahan CA, Ellebrecht CT, Obstfeld AE, Lacey SF, Melenhorst JJ, Nazimuddin F, Hwang WT, Maude SL, Wasik MA, Bagg A, Schuster S, Feldman MD, Porter DL, Grupp SA, June CH, Milone MC.

Blood. 2016 Jul 21;128(3):360-70. doi: 10.1182/blood-2016-01-694356. Epub 2016 May 10.

33.

Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets.

Bogusz AM, Bagg A.

Leuk Lymphoma. 2016 Sep;57(9):1991-2013. doi: 10.3109/10428194.2016.1173212. Epub 2016 Apr 27. Review.

PMID:
27121112
34.

Acute promyelocytic leukemia presenting as a paraspinal mass.

Shah NN, Stonecypher M, Gopal P, Luger S, Bagg A, Perl A.

J Community Support Oncol. 2016 Mar;14(3):126-9. doi: 10.12788/jcso.0220.

PMID:
27058871
35.

A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid Leukemia.

Sloan CE, Luskin MR, Boccuti AM, Sehgal AR, Zhao J, Daber RD, Morrissette JJ, Luger SM, Bagg A, Gimotty PA, Carroll M.

PLoS One. 2016 Apr 6;11(4):e0153016. doi: 10.1371/journal.pone.0153016. eCollection 2016.

36.

An extremely indolent T-cell leukemia: an 18-year follow-up.

Adediran S, Cornfield D, Bagg A, Agostino N.

J Community Support Oncol. 2016 Feb;14(2):76-8. doi: 10.12788/jcso.0190.

PMID:
26955661
37.

Clonal Replacement Underlies Spontaneous Remission in Paroxysmal Nocturnal Haemoglobinuria.

Babushok DV, Stanley N, Xie HM, Huang H, Bagg A, Olson TS, Bessler M.

Br J Haematol. 2017 Feb;176(3):487-490. doi: 10.1111/bjh.13963. Epub 2016 Feb 23. No abstract available.

38.

FLT3 Inhibitor-Associated Neutrophilic Dermatoses.

Varadarajan N, Boni A, Elder DE, Bagg A, Micheletti R, Perl AE, Rosenbach M.

JAMA Dermatol. 2016 Apr;152(4):480-2. doi: 10.1001/jamadermatol.2015.6121. No abstract available.

PMID:
26886840
39.

Transmission of an expanding donor-derived del(20q) clone through allogeneic hematopoietic stem cell transplantation without the development of a hematologic neoplasm.

Aikawa V, Porter D, Luskin MR, Bagg A, Morrissette JJ.

Cancer Genet. 2015 Dec;208(12):625-9. doi: 10.1016/j.cancergen.2015.10.003. Epub 2015 Nov 3.

PMID:
26628205
40.

Quizartinib elicits differential responses that correlate with karyotype and genotype of the leukemic clone.

Nybakken GE, Canaani J, Roy D, Morrissette JD, Watt CD, Shah NP, Smith CC, Bagg A, Carroll M, Perl AE.

Leukemia. 2016 Jun;30(6):1422-5. doi: 10.1038/leu.2015.320. Epub 2015 Nov 20. No abstract available.

41.

Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma.

Garfall AL, Maus MV, Hwang WT, Lacey SF, Mahnke YD, Melenhorst JJ, Zheng Z, Vogl DT, Cohen AD, Weiss BM, Dengel K, Kerr ND, Bagg A, Levine BL, June CH, Stadtmauer EA.

N Engl J Med. 2015 Sep 10;373(11):1040-7. doi: 10.1056/NEJMoa1504542.

42.

Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia.

Porter DL, Hwang WT, Frey NV, Lacey SF, Shaw PA, Loren AW, Bagg A, Marcucci KT, Shen A, Gonzalez V, Ambrose D, Grupp SA, Chew A, Zheng Z, Milone MC, Levine BL, Melenhorst JJ, June CH.

Sci Transl Med. 2015 Sep 2;7(303):303ra139. doi: 10.1126/scitranslmed.aac5415.

43.

NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic features.

Luskin MR, Huen AO, Brooks SA, Stewart C, Watt CD, Morrissette JJ, Lieberman DB, Bagg A, Rosenbach M, Perl AE.

Haematologica. 2015 Oct;100(10):e412-4. doi: 10.3324/haematol.2015.129346. Epub 2015 Jun 25. No abstract available.

44.

The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder.

Luskin MR, Heil DS, Tan KS, Choi S, Stadtmauer EA, Schuster SJ, Porter DL, Vonderheide RH, Bagg A, Heitjan DF, Tsai DE, Reshef R.

Am J Transplant. 2015 Oct;15(10):2665-73. doi: 10.1111/ajt.13324. Epub 2015 May 18.

45.

Molecular genetic evaluation of myeloproliferative neoplasms.

Azzato EM, Bagg A.

Int J Lab Hematol. 2015 May;37 Suppl 1:61-71. doi: 10.1111/ijlh.12353. Review.

PMID:
25976962
46.

Chronic lymphocytic leukemia with a t(8;14)(q24;q32): FISHing catches a (sheepish) red herring.

Rea B, Samulski TD, Strauser H, Aikawa V, Luger S, Bagg A.

Am J Hematol. 2015 Dec;90(12):1187-8. doi: 10.1002/ajh.24039. Epub 2015 Nov 17. No abstract available.

47.

Report from the OECI Oncology Days 2014.

van Harten W, Stanta G, Bussolati G, Riegman P, Hoefler G, Becker K, Folprecht G, Truini M, Haybaeck J, Buiga R, Dono M, Bagg A, López Guerrero J, Zupo S, Lemare F, de Lorenzo F, Goedbloed N, Razavi D, Lövey J, Cadariu P, Rollandi G, Paparo F, Pierotti M, Ciuleanu T, De Paoli P, Weiner G, Saghatchian M, Lombardo C.

Ecancermedicalscience. 2014 Dec 31;8:496. doi: 10.3332/ecancer.2014.496. eCollection 2014.

48.

Multifocal mantle cell lymphoma in situ in the setting of a composite lymphoma.

Sloan C, Xiong QB, Crivaro A, Steinman S, Bagg A.

Am J Clin Pathol. 2015 Feb;143(2):274-82; quiz 307. doi: 10.1309/AJCP06VIKFMTRCXD.

PMID:
25596254
49.

Coexistent BCR-ABL1 and JAK2 V617F: converting CML dwarves to ET staghorns with imatinib therapy.

Soderquist C, Bagg A.

Blood. 2014 Oct 9;124(15):2463. No abstract available.

PMID:
25436260
50.

Development and implementation of a custom integrated database with dashboards to assist with hematopathology specimen triage and traffic.

Azzato EM, Morrissette JJ, Halbiger RD, Bagg A, Daber RD.

J Pathol Inform. 2014 Aug 28;5(1):29. doi: 10.4103/2153-3539.139709. eCollection 2014.

Supplemental Content

Support Center